6,618
Participants
Start Date
December 15, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2028
Low dose computed tomography
"1. Participants belonging to modified Lung RADS category 1 and 2 at baseline screening will undergo the LDCT next year after the discussion with the physicians in charge.~2. Participants with nodules belonging to modified Lung RADS category 3 and 4, growing nodules, or new nodules found on follow-up LDCT scans will undergo repeat CT every 3 to 6 months or be referred for diagnostic workup depending on the size and characteristics of the nodules as the regular clinical practice.~3. Volume doubling time (VDT) will be performed in the special groups with Lung RADS category 3 or 4, but the nodules with solid components ≧ 6mm and \< 9mm. A repeat LDCT scan will be performed around 3 months after the baseline screening.~4. Check total bilirubin, urinary heavy metals,CRP, serum tumor marker, including CEA, alpha-fetal protein, etc.~5. Check pulmonary function test."
RECRUITING
Chung Shan Medical University, Taichung
RECRUITING
Hualien Tzu Chi Hospital, Hualien City
RECRUITING
National Taiwan University Hospital Hsin-Chu Branch, Hsinchu
NOT_YET_RECRUITING
E-Da Hospital, Kaohsiung City
RECRUITING
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
NOT_YET_RECRUITING
Ministry of Health and Welfare Shuang-Ho Hospital, New Taipei City
RECRUITING
National Taiwan University Hospital, Taipei
Collaborators (1)
AstraZeneca
INDUSTRY
Gee-Chen Chang
OTHER